Moderna declines after skyrocketing the previous session. Walmart falls as guidance fails to impress.
Can Moderna's melanoma vaccine cure cancer? Here's what the Phase 3 trial found, why experts aren't calling it a cure and ...
Concerns over elevated oil prices stemming from the Iran conflict and increasing government debt battered bond markets this ...
Tempus AI (TEM) stock surged 7% after BTIG raised its price target to $80 and Moderna's cancer trial win emphasized the value ...
Moderna Inc (NASDAQ:MRNA, XETRA:0QF)'s melanoma trial success is prompting Wall Street to assign new platform value to the company's oncology pipeline, Jefferies said, as investors look beyond its ...
Moderna and Merck scored a big win for their cancer vaccine on Wednesday. But analysts say it's too early to call it a home ...